Hangzhou hi tech: Director Zhou Jianhua completed the increase of 1007800 shares
Financial Associated Press, September 28 - Hangzhou hi tech announced that the company recently received the notification letter on the completion of the implementation of the share increase plan issued by director Zhou Jianhua. As of the disclosure date of the announcement, the implementation of Zhou Jianhua's share increase plan has been completed, with a total of 1.078 million shares of the company, with an increase of 85.623 billion yuan.
This text is a result of machine translation.
Related companies：
Briefing Jun 09, 2022 08:44 AM
· Technology
CITIC Securities: the development of the information innovation industry continues to deepen, with an annual scale of over 20/40 billion and is expected to speed up gradually
In-depth
Briefing Jun 08, 2022 08:23 PM
· Technology
Atlas solar response and Solaria patent dispute settlement
Aug 05, 2026 02:44 PM
Aug 05, 2026 02:35 PM
Research
Embodied AI2026 Full-Scope Report on Global Expansion of China's Embodied Intelligence Enterprises
Apr 27, 2026 02:33 PM
Jan 30, 2026 06:00 PM
Briefing Jan 25, 2022 04:30 PM
· Technology
Wal nuclear material: the holding subsidiary is recognized as a high-tech enterprise
Briefing Dec 09, 2021 01:09 PM
· Technology
Digital productivity service provider "Rongzhi information" completes a new round of strategic financing
Briefing Oct 15, 2021 06:20 PM
· Technology
UFIDA network: some directors, supervisors and senior managers plan to reduce their holdings of no more than 0.0454% of the company's shares in total
Low-altitude Economy
EHang and Sri Lanka Explore Regulatory Path for Pilotless eVTOL Services
EHang Holdings (亿航智能) and Sri Lanka’s Civil Aviation Authority have held technical discussions on the possible introduction of electric vertical take-off and landing aircraft, or eVTOLs, into the country’s aviation system.
Yesterday 02:49 PM
Healthcare
Kanghong’s Conbercept Receives Marketing Authorization in Guyana
Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).
Yesterday 02:48 PM
Briefing Sep 15, 2021 04:56 PM
Italy Mattioli family's strategic investment in manfuli China is 10 million euros
Briefing Sep 06, 2021 06:49 PM
· Automotive
Chujiang Xincai: recently received a total of 27.5481 million yuan of government subsidies related to income
Briefing Aug 20, 2021 07:13 PM
UFIDA network: it has applied to the CSRC for resumption of examination of non-public offering of shares
Screentime
Perfect World’s NTE Tops RMB2 Billion in Global Gross Billings
Perfect World Games (完美世界游戏) said its self-developed open-world action RPG Neverness to Everness (NTE, 《异环》) had generated more than RMB2 billion in cumulative global gross billings as of Aug. 18, according to the company’s 2026 interim report.
Yesterday 02:46 PM
Briefing Aug 20, 2021 04:50 PM
· Technology
Zhenghai magnetic materials: Zhao Juntao, director and deputy general manager, completed the reduction of 350000 shares
Briefing Aug 02, 2021 03:56 PM
Shuangjian shares: the application for issuing convertible bonds was approved by the CSRC
See more
Read next
Insight
In-depth
Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors
Aug 04, 2026 11:21 AM
Insight
In-depth
Low-altitude Economy · Interview
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 31, 2026 02:44 PM